growth hormone deficiency
Endocrinology · 2016–2023
10decisions
3medicines
4carried consumer input
94individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| somatropin Treatment of severe late onset growth hormone deficiency (GHD) in adults. The drug is indicated for replacement therapy in adults with pronounced GHD as… | Sep 2023 | Recommended with restriction | none received |
| somapacitan Treatment of paediatric patients with growth hormone deficiency (GHD), including short stature associated with biochemical GHD (SSABGHD) and short stature slow… | Jul 2023 | Recommended with restriction | 4 individuals |
| somapacitan Treatment of adults with growth hormone deficiency (AGHD), including both adult-onset AGHD secondary to organic hypothalamic or pituitary disease and… | Mar 2022 | Recommended with restriction | 10 individuals Australian Pituitary Foundation |
| somatrogon Treatment of growth hormone deficiency in paediatric patients, specifically for short stature associated with biochemical growth hormone deficiency (SSABGHD)… | Mar 2022 | Recommended with restriction | 12 individuals Australian Pituitary Foundation · Pediatric Endocrine Society · Argrntine Federation |
| somatropin Treatment of severe growth hormone deficiency in adults, including those with childhood-onset growth hormone deficiency due to congenital, genetic or… | Aug 2019 | Noted | no section in document |
| somatropin Treatment of adults with severe growth hormone deficiency. | Mar 2019 | Recommended with restriction | no section in document |
| somatropin Short stature and slow growth. Re-listing of a previously listed somatropin product under a new brand name and sponsor. | Jul 2018 | Recommended with restriction | none received |
| somatropin Treatment of adults with severe growth hormone deficiency (GHD) and substantially impaired quality of life at baseline. | Jul 2017 | Recommended with restriction | none received |
| somatropin Treatment of short stature due to decreased or failed secretion of pituitary growth hormone, severe growth hormone deficiency in adults, growth disturbances in… | Mar 2016 | Recommended | none received |
| somatropin Treatment of adults with severe growth hormone deficiency (GHD) and substantially impaired quality of life at baseline. | Nov 2016 | Deferred | 68 individuals |
Who spoke
Australian Pituitary Foundation · Pediatric Endocrine Society · Argrntine Federation
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 4 of 10 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.